
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $2B | $2.4B | $2.6B | $2.8B | $2.7B | |
Revenue Growth (YoY) | -13.22% | 24.51% | 6.81% | 6.99% | -1.22% | |
Cost of Revenues | $1.3B | $1.6B | $1.7B | $1.8B | $1.7B | |
Gross Profit | $682.5M | $838M | $885.5M | $1B | $1B | |
Gross Profit Margin | 35% | 34.51% | 34.15% | 36.61% | 37.85% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $458.7M | $512.8M | $533.4M | $587.5M | $579.8M | |
Other Inc / (Exp) | -$21.6M | -$7.7M | -$14M | -$24.1M | -$22.4M | |
Operating Expenses | $458.7M | $512.8M | $533.4M | $587.5M | $579.8M | |
Operating Income | $223.8M | $325.2M | $352.2M | $428.3M | $457.7M | |
Net Interest Expenses | -- | -- | $38M | $85.1M | $64.9M | |
EBT. Incl. Unusual Items | $205.8M | $319.1M | $300.3M | $319.1M | $370.4M | |
Earnings of Discontinued Ops. | -- | -- | -$3.1M | -$12.3M | -$22.3M | |
Income Tax Expense | $46M | $80.4M | $69.2M | $95.7M | $77.3M | |
Net Income to Company | $159.9M | $238.7M | $228M | $211M | $270.7M | |
Minority Interest in Earnings | -$2.5M | -$3.6M | -$4.3M | -$5.7M | -$5.9M | |
Net Income to Common Excl Extra Items | $157.4M | $235.1M | $223.7M | $205.3M | $264.8M | |
Basic EPS (Cont. Ops) | $2.62 | $3.92 | $3.70 | $3.39 | $4.36 | |
Diluted EPS (Cont. Ops) | $2.62 | $3.92 | $3.69 | $3.36 | $4.31 | |
Weighted Average Basic Share | $60M | $60M | $60.1M | $60.2M | $60.4M | |
Weighted Average Diluted Share | $60M | $60M | $60.2M | $60.7M | $61.1M | |
EBITDA | $300.4M | $401.1M | $404.2M | $479.2M | $502.1M | |
EBIT | $223.8M | $325.2M | $338.2M | $404.2M | $435.3M | |
Revenue (Reported) | $2B | $2.4B | $2.6B | $2.8B | $2.7B | |
Operating Income (Reported) | $223.8M | $325.2M | $352.2M | $428.3M | $457.7M | |
Operating Income (Adjusted) | $223.8M | $325.2M | $338.2M | $404.2M | $435.3M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $568.1M | $647.9M | $684M | $689.7M | $678.1M | |
Revenue Growth (YoY) | -- | 14.04% | 5.57% | 0.84% | -1.68% | |
Cost of Revenues | $368.3M | $423.6M | $436.6M | $434.7M | $422.9M | |
Gross Profit | $199.8M | $224.3M | $247.4M | $255M | $255.2M | |
Gross Profit Margin | 35.17% | 34.62% | 36.17% | 36.97% | 37.63% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $124.4M | $135.4M | $147.3M | $142.5M | $140.9M | |
Other Inc / (Exp) | -$3.1M | -$5.3M | -$9.4M | -$14.1M | -$4.5M | |
Operating Expenses | $124.4M | $135.4M | $147.3M | $142.5M | $140.9M | |
Operating Income | $75.4M | $88.9M | $100.1M | $112.6M | $114.3M | |
Net Interest Expenses | -- | -- | $19.5M | $17.1M | $16.8M | |
EBT. Incl. Unusual Items | $72.5M | $84.2M | $71.2M | $81.4M | $93.1M | |
Earnings of Discontinued Ops. | -- | -$2M | -$913K | -$1.3M | -$2.7M | |
Income Tax Expense | $14M | $25.7M | $37M | $18.5M | $20.5M | |
Net Income to Company | $58.5M | $56.4M | $33.2M | $61.6M | $69.8M | |
Minority Interest in Earnings | -$876K | -$966K | -$1.3M | -$1.6M | -$2.5M | |
Net Income to Common Excl Extra Items | $57.7M | $55.4M | $31.9M | $60M | $67.4M | |
Basic EPS (Cont. Ops) | $0.96 | $0.93 | $0.52 | $0.99 | $1.10 | |
Diluted EPS (Cont. Ops) | $0.96 | $0.93 | $0.52 | $0.98 | $1.10 | |
Weighted Average Basic Share | $60M | $60M | $60.1M | $60.3M | $60.6M | |
Weighted Average Diluted Share | $60M | $60M | $60.5M | $61M | $61.3M | |
EBITDA | $94.1M | $105.6M | $112.5M | $114.9M | $127.3M | |
EBIT | $75.4M | $88.9M | $90.7M | $98.5M | $109.8M | |
Revenue (Reported) | $568.1M | $647.9M | $684M | $689.7M | $678.1M | |
Operating Income (Reported) | $75.4M | $88.9M | $100.1M | $112.6M | $114.3M | |
Operating Income (Adjusted) | $75.4M | $88.9M | $90.7M | $98.5M | $109.8M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | -- | $2.5B | $2.6B | $2.8B | $2.7B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | $1.6B | $1.7B | $1.8B | $1.7B | |
Gross Profit | -- | $862.5M | $908.6M | $1B | $1B | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | -- | $523.8M | $545.2M | $582.6M | $578.2M | |
Other Inc / (Exp) | -$3.1M | -$10M | -$18.1M | -$28.7M | -$12.8M | |
Operating Expenses | -- | $523.8M | $545.2M | $582.6M | $578.2M | |
Operating Income | -- | $338.7M | $363.4M | $440.7M | $459.4M | |
Net Interest Expenses | -- | -- | $58M | $82.7M | $64.6M | |
EBT. Incl. Unusual Items | -- | $330.7M | $287.2M | $329.3M | $382.1M | |
Earnings of Discontinued Ops. | -- | -$2M | -$2M | -$12.7M | -$23.7M | |
Income Tax Expense | -- | $92.2M | $80.4M | $77.2M | $79.3M | |
Net Income to Company | -- | $236.5M | $204.8M | $239.4M | $279M | |
Minority Interest in Earnings | -$876K | -$3.7M | -$4.6M | -$6.1M | -$6.7M | |
Net Income to Common Excl Extra Items | -- | $232.9M | $200.2M | $233.3M | $272.3M | |
Basic EPS (Cont. Ops) | -- | $3.89 | $3.30 | $3.85 | $4.46 | |
Diluted EPS (Cont. Ops) | -- | $3.89 | $3.29 | $3.81 | $4.44 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | -- | $412.6M | $411.1M | $481.6M | $514.5M | |
EBIT | -- | $338.7M | $339.9M | $412M | $446.6M | |
Revenue (Reported) | -- | $2.5B | $2.6B | $2.8B | $2.7B | |
Operating Income (Reported) | -- | $338.7M | $363.4M | $440.7M | $459.4M | |
Operating Income (Adjusted) | -- | $338.7M | $339.9M | $412M | $446.6M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $568.1M | $647.9M | $684M | $689.7M | $678.1M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $368.3M | $423.6M | $436.6M | $434.7M | $422.9M | |
Gross Profit | $199.8M | $224.3M | $247.4M | $255M | $255.2M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $124.4M | $135.4M | $147.3M | $142.5M | $140.9M | |
Other Inc / (Exp) | -$3.1M | -$5.3M | -$9.4M | -$14.1M | -$4.5M | |
Operating Expenses | $124.4M | $135.4M | $147.3M | $142.5M | $140.9M | |
Operating Income | $75.4M | $88.9M | $100.1M | $112.6M | $114.3M | |
Net Interest Expenses | -- | -- | $19.5M | $17.1M | $16.8M | |
EBT. Incl. Unusual Items | $72.5M | $84.2M | $71.2M | $81.4M | $93.1M | |
Earnings of Discontinued Ops. | -- | -$2M | -$913K | -$1.3M | -$2.7M | |
Income Tax Expense | $14M | $25.7M | $37M | $18.5M | $20.5M | |
Net Income to Company | $58.5M | $56.4M | $33.2M | $61.6M | $69.8M | |
Minority Interest in Earnings | -$876K | -$966K | -$1.3M | -$1.6M | -$2.5M | |
Net Income to Common Excl Extra Items | $57.7M | $55.4M | $31.9M | $60M | $67.4M | |
Basic EPS (Cont. Ops) | $0.96 | $0.93 | $0.52 | $0.99 | $1.10 | |
Diluted EPS (Cont. Ops) | $0.96 | $0.93 | $0.52 | $0.98 | $1.10 | |
Weighted Average Basic Share | $60M | $60M | $60.1M | $60.3M | $60.6M | |
Weighted Average Diluted Share | $60M | $60M | $60.5M | $61M | $61.3M | |
EBITDA | $94.1M | $105.6M | $112.5M | $114.9M | $127.3M | |
EBIT | $75.4M | $88.9M | $90.7M | $98.5M | $109.8M | |
Revenue (Reported) | $568.1M | $647.9M | $684M | $689.7M | $678.1M | |
Operating Income (Reported) | $75.4M | $88.9M | $100.1M | $112.6M | $114.3M | |
Operating Income (Adjusted) | $75.4M | $88.9M | $90.7M | $98.5M | $109.8M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $49.2M | $41.2M | $72M | $102M | $249.4M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $329.6M | $383.5M | $374.3M | $385.2M | $370.3M | |
Inventory | $313.4M | $420.1M | $416.8M | $392.9M | $403.7M | |
Prepaid Expenses | $49.3M | $51.9M | $56.6M | $61.8M | $55.7M | |
Other Current Assets | $63.5M | $67.4M | $68.9M | $55.9M | $69.3M | |
Total Current Assets | $804.9M | $964.1M | $988.7M | $997.7M | $1.1B | |
Property Plant And Equipment | $395.9M | $394.2M | $376.3M | $389.9M | $388.2M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $1.6B | $1.5B | $1.5B | $1.6B | $1.7B | |
Other Intangibles | $577.4M | $521.4M | $517.2M | $499.5M | $488M | |
Other Long-Term Assets | $54.4M | $48.5M | $342.2M | $353.1M | $357.4M | |
Total Assets | $3.4B | $3.5B | $3.8B | $3.8B | $4B | |
Accounts Payable | $241.3M | $345.5M | $316.3M | $306.6M | $318.5M | |
Accrued Expenses | $9.5M | $16.1M | $18.3M | $19.4M | $25.4M | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | $15M | |
Current Portion Of Capital Lease Obligations | $18.6M | $20.5M | $18.7M | $22.8M | $21.5M | |
Other Current Liabilities | $45.8M | $43.8M | $85.1M | $84.7M | $85.6M | |
Total Current Liabilities | $460.8M | $596.6M | $601.6M | $620.1M | $632.1M | |
Long-Term Debt | -- | -- | $1.2B | $1B | $1.1B | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $841.1M | $959.5M | $2.4B | $2.2B | $2.2B | |
Common Stock | $2.9B | -- | $60K | $60K | $61K | |
Other Common Equity Adj | -$396.2M | -$460.9M | -$675M | -$624.3M | -$729.6M | |
Common Equity | $2.5B | $2.5B | $1.4B | $1.6B | $1.8B | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | $42.1M | $41M | $38.3M | $40.3M | $39.2M | |
Total Equity | $2.5B | $2.5B | $1.4B | $1.6B | $1.8B | |
Total Liabilities and Equity | $3.4B | $3.5B | $3.8B | $3.8B | $4B | |
Cash and Short Terms | $49.2M | $41.2M | $72M | $102M | $249.4M | |
Total Debt | -- | -- | $1.2B | $1B | $1.1B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | -- | $56.6M | $82.1M | $76.5M | $291.3M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | -- | $410.2M | $404.1M | $430.1M | $414.8M | |
Inventory | -- | $462.5M | $448.3M | $405.6M | $450.7M | |
Prepaid Expenses | -- | $59M | $55.8M | $60.4M | $56.9M | |
Other Current Assets | -- | $59.7M | $70.3M | $70.1M | $72.2M | |
Total Current Assets | -- | $1B | $1.1B | $1B | $1.3B | |
Property Plant And Equipment | -- | $388.3M | $381.1M | $384.6M | $393.8M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | -- | $1.5B | $1.6B | $1.6B | $1.7B | |
Other Intangibles | -- | $508.5M | $518.4M | $484.2M | $502.9M | |
Other Long-Term Assets | -- | $322.5M | $324.7M | $329M | $350M | |
Total Assets | -- | $3.8B | $3.8B | $3.8B | $4.2B | |
Accounts Payable | -- | $369M | $355.3M | $338.4M | $349.7M | |
Accrued Expenses | -- | $13.4M | $10.8M | $11.2M | $29.1M | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | $17.8M | |
Current Portion Of Capital Lease Obligations | -- | $18.9M | $22.8M | $22.9M | $21M | |
Other Current Liabilities | -- | $85M | $82.8M | $95.6M | $92.6M | |
Total Current Liabilities | -- | $652.4M | $630.4M | $631.3M | $672M | |
Long-Term Debt | -- | -- | $1.2B | $992.8M | $1.1B | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | -- | $1.3B | $2.4B | $2.1B | $2.3B | |
Common Stock | -- | $3B | $60K | $60K | $61K | |
Other Common Equity Adj | -- | -$564M | -$636.7M | -$647.7M | -$651.9M | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | $40.5M | $38.7M | $41.6M | $40.7M | |
Total Equity | -- | $2.5B | $1.5B | $1.7B | $2B | |
Total Liabilities and Equity | -- | $3.8B | $3.8B | $3.8B | $4.2B | |
Cash and Short Terms | -- | $56.6M | $82.1M | $76.5M | $291.3M | |
Total Debt | -- | -- | $1.2B | $992.8M | $1.1B |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $159.9M | $238.7M | $228M | $211M | $270.7M | |
Depreciation & Amoritzation | $76.6M | $75.9M | $66M | $75M | $66.8M | |
Stock-Based Compensation | $6.4M | $6.3M | $13M | $16.1M | $19.8M | |
Change in Accounts Receivable | $27.7M | -$67.9M | -$8.1M | -$6M | -$4.8M | |
Change in Inventories | $34.8M | -$117.4M | -$10.1M | $18M | -$22.5M | |
Cash From Operations | $309.2M | $250.7M | $214.4M | $330.5M | $355.4M | |
Capital Expenditures | $40.1M | $35.6M | $40.2M | $48.2M | $51.8M | |
Cash Acquisitions | -- | -$4.9M | -$149M | -$18.7M | -$153.7M | |
Cash From Investing | -$34.6M | -$35.3M | -$184.4M | -$62.2M | -$205.7M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -$6.1M | -$13.3M | -$17M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | $673K | $1.8B | $574.2M | $905M | |
Long-Term Debt Repaid | -$190K | -- | -$585.5M | -$775.7M | -$839.5M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$326.2M | -$222.2M | -$1.2B | -$4.9M | -$16.8M | |
Cash From Financing | -$326.4M | -$221.6M | $7.6M | -$219.7M | $31.7M | |
Beginning Cash (CF) | $104.8M | $49.2M | $41.2M | $72M | $102M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$51.8M | -$6.1M | $37.5M | $48.5M | $181.4M | |
Ending Cash (CF) | $49.2M | $41.2M | $72M | $102M | $249.4M | |
Levered Free Cash Flow | $269M | $215.2M | $174.1M | $282.3M | $303.6M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $58.5M | $56.4M | $33.2M | $61.6M | $69.8M | |
Depreciation & Amoritzation | $18.7M | $16.7M | $21.9M | $16.4M | $17.5M | |
Stock-Based Compensation | $1.6M | $1.7M | $3M | $4.1M | $5.4M | |
Change in Accounts Receivable | -$35M | -$29.8M | -$21M | -$48.9M | -$32M | |
Change in Inventories | -$29.4M | -$41.9M | -$21.6M | -$16.1M | -$35.4M | |
Cash From Operations | $62.8M | $16.1M | $38.1M | $44.5M | $35.4M | |
Capital Expenditures | $4.7M | $5.9M | $7.7M | $7.4M | $7.3M | |
Cash Acquisitions | -$4.9M | -- | -$18.7M | -$18.1M | -- | |
Cash From Investing | -$9.4M | -$3.2M | -$25.7M | -$26.6M | -$2.7M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -$3M | -$3.6M | -$4.9M | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | $187M | $115M | -- | |
Long-Term Debt Repaid | -$3K | -$511K | -$189.8M | -$141.3M | -$2.5M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$56.1M | $406K | -$1.2M | -$4M | -$5.8M | |
Cash From Financing | -$56.1M | -$105K | -$7M | -$33.9M | -$13.1M | |
Beginning Cash (CF) | $49.2M | $41.2M | $72M | $102M | $249.4M | |
Foreign Exchange Rate Adjustment | -$1.4M | $2.6M | $4.8M | -$9.4M | $22.4M | |
Additions / Reductions | -$2.7M | $12.8M | $5.3M | -$16.1M | $19.6M | |
Ending Cash (CF) | $45.2M | $56.6M | $82.1M | $76.5M | $291.3M | |
Levered Free Cash Flow | $58.1M | $10.2M | $30.4M | $37.1M | $28.1M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | $236.5M | $204.8M | $239.4M | $279M | |
Depreciation & Amoritzation | -- | $73.9M | $71.2M | $69.6M | $67.9M | |
Stock-Based Compensation | $1.6M | $6.4M | $14.2M | $17.3M | $21M | |
Change in Accounts Receivable | -- | -$62.6M | $643K | -$33.9M | $12.1M | |
Change in Inventories | -- | -$129.9M | $10.2M | $23.5M | -$41.8M | |
Cash From Operations | -- | $204M | $236.3M | $336.9M | $346.3M | |
Capital Expenditures | $4.7M | $36.8M | $42M | $47.9M | $51.7M | |
Cash Acquisitions | -$4.9M | -$26K | -$167.8M | -$18M | -$135.6M | |
Cash From Investing | -- | -$29M | -$207M | -$63.1M | -$181.8M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -$9.1M | -$13.9M | -$18.2M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | $673K | $2B | $502.2M | $790M | |
Long-Term Debt Repaid | -- | -$508K | -$774.7M | -$727.2M | -$700.8M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -$165.7M | -$1.2B | -$7.6M | -$18.6M | |
Cash From Financing | -- | -$165.6M | $615K | -$246.6M | $52.5M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -- | $9.4M | $29.9M | $27.2M | $217M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -- | $167.2M | $194.3M | $289M | $294.7M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $58.5M | $56.4M | $33.2M | $61.6M | $69.8M | |
Depreciation & Amoritzation | $18.7M | $16.7M | $21.9M | $16.4M | $17.5M | |
Stock-Based Compensation | $1.6M | $1.7M | $3M | $4.1M | $5.4M | |
Change in Accounts Receivable | -$35M | -$29.8M | -$21M | -$48.9M | -$32M | |
Change in Inventories | -$29.4M | -$41.9M | -$21.6M | -$16.1M | -$35.4M | |
Cash From Operations | $62.8M | $16.1M | $38.1M | $44.5M | $35.4M | |
Capital Expenditures | $4.7M | $5.9M | $7.7M | $7.4M | $7.3M | |
Cash Acquisitions | -$4.9M | -- | -$18.7M | -$18.1M | -- | |
Cash From Investing | -$9.4M | -$3.2M | -$25.7M | -$26.6M | -$2.7M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -$3M | -$3.6M | -$4.9M | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | $187M | $115M | -- | |
Long-Term Debt Repaid | -$3K | -$511K | -$189.8M | -$141.3M | -$2.5M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$56.1M | $406K | -$1.2M | -$4M | -$5.8M | |
Cash From Financing | -$56.1M | -$105K | -$7M | -$33.9M | -$13.1M | |
Beginning Cash (CF) | $49.2M | $41.2M | $72M | $102M | $249.4M | |
Foreign Exchange Rate Adjustment | -$1.4M | $2.6M | $4.8M | -$9.4M | $22.4M | |
Additions / Reductions | -$2.7M | $12.8M | $5.3M | -$16.1M | $19.6M | |
Ending Cash (CF) | $45.2M | $56.6M | $82.1M | $76.5M | $291.3M | |
Levered Free Cash Flow | $58.1M | $10.2M | $30.4M | $37.1M | $28.1M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.